Nanomedicine for Intranasal Delivery to Improve Brain Uptake
- PMID: 29034836
- DOI: 10.2174/1567201814666171013150534
Nanomedicine for Intranasal Delivery to Improve Brain Uptake
Abstract
Intranasal drug delivery system provides distinct advantage over conventional drug delivery system for a drug that is pharmacokenetically or biologically unstable. Major concern for the treatment of central nervous system diseases is, low concentration of therapeutically active molecule within brain as blood brain barrier is creating obstacle, where intranasal drug delivery provides direct transport of therapeutically active moiety into brain via olfactory or trigeminal pathway. Nasal mucosa provides distinct advantages like improved bioavailability, law dose and quick onset of action and high patient compliance, and the major disadvantage is residence time of drug and irreversible entrapment of drug. This article provides anatomical and physiological information about nasal route and various factors. Article discusses various types of nanoparticles used intranasally and moreover article also emphasizes patents, formulation under development and some.
Keywords: Brain uptake; drug delivery system; intranasal delivery; nanomedicine; nasal route; pharmacokinetic..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Similar articles
-
Mathematical Modeling and Simulation to Investigate the CNS Transport Characteristics of Nanoemulsion-Based Drug Delivery Following Intranasal Administration.Pharm Res. 2019 Mar 28;36(5):75. doi: 10.1007/s11095-019-2610-y. Pharm Res. 2019. PMID: 30923914
-
Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review.Recent Pat Drug Deliv Formul. 2016;10(2):156-64. doi: 10.2174/1872211310666160321123936. Recent Pat Drug Deliv Formul. 2016. PMID: 26996366 Review.
-
Nanoparticles for direct nose-to-brain delivery of drugs.Int J Pharm. 2009 Sep 8;379(1):146-57. doi: 10.1016/j.ijpharm.2009.06.019. Epub 2009 Jun 23. Int J Pharm. 2009. PMID: 19555750 Review.
-
Formulation and physiological factors influencing CNS delivery upon intranasal administration.Crit Rev Ther Drug Carrier Syst. 2006;23(4):319-47. doi: 10.1615/critrevtherdrugcarriersyst.v23.i4.20. Crit Rev Ther Drug Carrier Syst. 2006. PMID: 17341201 Review.
-
Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.Expert Opin Drug Deliv. 2013 Jul;10(7):957-72. doi: 10.1517/17425247.2013.790887. Epub 2013 Apr 16. Expert Opin Drug Deliv. 2013. PMID: 23586809 Review.
Cited by
-
Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases.Pharmaceutics. 2021 Nov 8;13(11):1897. doi: 10.3390/pharmaceutics13111897. Pharmaceutics. 2021. PMID: 34834311 Free PMC article. Review.
-
Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances.Asian J Pharm Sci. 2019 Sep;14(5):480-496. doi: 10.1016/j.ajps.2018.09.005. Epub 2018 Oct 22. Asian J Pharm Sci. 2019. PMID: 32104476 Free PMC article. Review.
-
Different Methods and Formulations of Drugs and Vaccines for Nasal Administration.Pharmaceutics. 2022 May 17;14(5):1073. doi: 10.3390/pharmaceutics14051073. Pharmaceutics. 2022. PMID: 35631663 Free PMC article. Review.
-
Organotropic drug delivery: Synthetic nanoparticles and extracellular vesicles.Biomed Microdevices. 2019 Apr 15;21(2):46. doi: 10.1007/s10544-019-0396-7. Biomed Microdevices. 2019. PMID: 30989386 Free PMC article. Review.
-
Recent Advances in Intranasal Administration for Brain-Targeting Delivery: A Comprehensive Review of Lipid-Based Nanoparticles and Stimuli-Responsive Gel Formulations.Int J Nanomedicine. 2024 Feb 23;19:1767-1807. doi: 10.2147/IJN.S439181. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38414526 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical